Skip to main content
Clinical Trials/NCT00717392
NCT00717392
Completed
Not Applicable

Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders

Sheba Medical Center1 site in 1 country40 target enrollmentSeptember 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Sheba Medical Center
Enrollment
40
Locations
1
Primary Endpoint
Improving the parameters of autism
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. The purpose of the current research is to evaluate the efficacy of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy will show better outcomes than children with the same problems who are not treated with hippotherapy.

Detailed Description

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. Most studies that tested hippotherapy were uncontrolled and focused on motor problems, such as cerebral palsy. Today, hippotherapy is used for various developmental problems such as Attention deficit / Hyperactivity disorder (ADHD) and Autism spectrum disorder (ASD), without clear information about its efficacy for these populations. The purpose of the current research is to evaluate the efficacy of 6 months of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy for 6 months will show better outcomes than children with the same problems who are not treated with hippotherapy. Assessment: * BRIEF questionnaire * Stony Brook Questionnaire All questionnaires will be applied at the beginning of the study and after 6 months.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
July 2012
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Lidia Gabis MD

Director, The Weinberg Child Development Center

Sheba Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age: 5-17 years.
  • A diagnosis of ADHD or ASD.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Improving the parameters of autism

Time Frame: Repetitive behaviors

Repetitive behaviors Eye contact Communication

Study Sites (1)

Loading locations...

Similar Trials